Clinical Trial Update: Using Novel Imaging to More Safely Treat Neuroendocrine Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial at University of Wisconsin–Madison evaluating novel imaging to treat neuroendocrine tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor | Phase 1 | Status: RECRUITING